Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies.
about
Targeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC)T lymphocytes targeting native receptorsHostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologistsImmunologically augmented skin flap as a novel dendritic cell vaccine against head and neck cancer in a rat modelTailored immunotherapy for HPV positive head and neck squamous cell cancerImmunologic special forces: anti-pathogen cytotoxic T-lymphocyte immunotherapy following hematopoietic stem cell transplantation.T cells for viral infections after allogeneic hematopoietic stem cell transplantLeveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicinePotential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer.Antigen-specific T cell therapies for cancer.Immunotherapy against cancer-related viruses.Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections.Adoptive cellular immunotherapy for virus-associated cancers: a new paradigm in personalized medicine.Host genetic influence on papillomavirus-induced tumors in the horse.Therapeutic vaccines for high-risk HPV-associated diseases.Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12.Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.
P2860
Q26765429-AB31F2CC-83CD-4406-ADF2-80F2AD199325Q26853345-8941289F-8A79-4157-864C-0793B997DB70Q35090797-9D91DB89-8EDD-4FA5-846C-4AA64984B2A7Q35439353-DDC89CFA-BDC1-4664-AE4B-7C0EC620A650Q35623980-D64D763C-86BB-4D16-A4CD-986233568740Q36956443-A2811A01-E94A-4505-AFB8-39B160B27B3FQ37058107-DA1DCA31-972C-4DA2-8F99-7BFB561DEF33Q37224420-D0E4F48F-09D0-476F-9DC7-6CD77C67FC20Q37399278-92648AAA-59A5-465E-971E-B5465ABF2AA4Q38544740-2AE59D2A-DB90-49ED-910C-C82B034E38F3Q38778924-E697754D-257F-491E-9DDA-D38BCF1405BBQ38797555-BDFAE904-865D-4B17-950F-E7E7B6BADC17Q39044990-2ECB2273-8E63-4FCF-BDBF-61EAAF286A62Q40731443-AB656419-2D97-4D20-B320-F5FBC8B5BB9BQ47255618-878BD5E5-BED5-48F6-8E59-F1D8073C13AEQ52691583-44F090A4-597E-45EC-8214-F742AB1F65DCQ55652233-B7EC1FDC-243C-4447-995B-D0248388BA6B
P2860
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Human papillomavirus type 16 E ...... f HPV-associated malignancies.
@ast
Human papillomavirus type 16 E ...... f HPV-associated malignancies.
@en
Human papillomavirus type 16 E ...... f HPV-associated malignancies.
@nl
type
label
Human papillomavirus type 16 E ...... f HPV-associated malignancies.
@ast
Human papillomavirus type 16 E ...... f HPV-associated malignancies.
@en
Human papillomavirus type 16 E ...... f HPV-associated malignancies.
@nl
prefLabel
Human papillomavirus type 16 E ...... f HPV-associated malignancies.
@ast
Human papillomavirus type 16 E ...... f HPV-associated malignancies.
@en
Human papillomavirus type 16 E ...... f HPV-associated malignancies.
@nl
P2093
P2860
P1476
Human papillomavirus type 16 E ...... of HPV-associated malignancies
@en
P2093
Ann M Leen
Barbara Savoldo
Cliona M Rooney
Erich M Sturgis
Gayatri M Vyas
Helen E Heslop
Malcolm K Brenner
Neeharika Narala
Ulrike Gerdemann
P2860
P356
10.1097/CJI.0B013E318279652E
P577
2013-01-01T00:00:00Z